| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |